Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » ELF’s TB Community Advisory Group to present at TB conference
ELF TB Community Advisory Group to speak at this year’s virtual World Conference on Lung Health. Register to attend the virtual Community Connect part of the conference for free!
ELF is working with UNITE4TB, a project that plans to speed up the development of treatment for tuberculosis (TB). To make sure the project takes on board the views of people affected by TB, we have set up a Community Advisory Group (CAG). The CAG includes people with lived experience of TB and of working with TB communities throughout the world.
On 9 November, the CAG will speak at this year’s virtual World Conference on Lung Health. The CAG will be part of the Community Connect session, where they will explain how to engage the community in TB research. They will also share what they have achieved so far in UNITE4TB.
You can register to attend the virtual Community Connect part of the conference here for free.
You can find out more about the UNITE4TB project: www.unite4tb.org
Read more about ELF’s role in the project: https://europeanlung.org/en/news-and-blog/launch-of-unite4tb-partnership-marks-a-new-era-in-tuberculosis-treatment-development/
UNITE4TB receives funding from the Innovative Medicines Initiative 2 Joint Undertaking. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme. EFPIA/AP contribute to 50% of funding, whereas the contribution of DZIF and the LMU University Hospital Munich has been granted by the German Federal Ministry of Education and Research. www.imi.europa.eu
Content on this website reflects only the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79